Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective The primary objective of this review is to determine which technique (test) for assessing MGMT methylation status best predicts overall survival in people diagnosed with glioblastoma who are treate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: McAleenan, Alexandra, Howell, Amy, Kernohan, Ashleigh, Faulkner, Claire L, Dawson, Sarah, Wragg, Christopher, Jefferies, Sarah, Brandner, Sebastian, Vale, Luke, Higgins, Julian P T, Kurian, Kathreena M
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2019
Teme:
Medicine General & Introductory Medical Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013316
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki